Author: gradycampbell

Categories
Company News

Zyston Unveils CyberCAST 3.0: A Revolutionary Advancement in Continuous Threat Exposure Management

News and Insights

Index

Zyston Unveils CyberCAST 3.0: A Revolutionary Advancement in Continuous Threat Exposure Management

Dallas, TX, May 17, 2024 – Zyston, renowned for its pioneering cybersecurity solutions, proudly unveils CyberCAST 3.0, a groundbreaking update to its flagship platform. The newest launch highlights Zyston’s steadfast commitment to pioneering cybersecurity program management enabling technology, tackling the ongoing challenge of Continuous Threat Exposure Management for organizations.

At the heart of CyberCAST 3.0 lies a robust risk management framework and an integrated offensive security capability, enabling organizations to proactively identify, assess, and mitigate cybersecurity risks, fostering integrated risk management to safeguard digital assets effectively.

“CyberCAST 3.0 is the industry leader in cybersecurity program management. CyberCAST provides customers with a cybersecurity score and a strategic and tactical roadmap for program improvement. Utilizing AI, CyberCAST is a highly time-efficient and cost-effective solution.”  -Craig Stamm, Zyston CEO.

The new features introduced in CyberCAST 3.0 are set to revolutionize how organizations assess and enhance their cybersecurity posture, offering unparalleled value and efficiency:

1. AI Assist Assessment

Zyston’s CyberCAST 3.0 introduces an industry-first AI Assist Assessment feature, setting a new standard in cybersecurity program management technology. This proprietary engine employs real-time analysis of customer policy documents against the NIST CSF 2.0 framework to provide instant responses to the CyberCAST SAQ (Self-Assessment Questionnaire), streamlining compliance processes like never before. By leveraging AI technology, organizations can efficiently evaluate their cybersecurity posture in as little as two minutes, ensuring adherence to industry standards and fortifying defenses against evolving threats with unprecedented speed and accuracy.

2. Integration of NIST Cybersecurity Framework Version 2.0:

CyberCAST is among the first platforms to incorporate the NIST Cybersecurity Framework (CSF) version 2.0, released in February. This integration expands the framework’s capabilities, particularly in governance, providing a comprehensive approach to compliance and integrated risk management. Zyston’s pioneering implementation ensures that organizations have access to the latest standards and methodologies to strengthen their cybersecurity programs.

3. Guided Self-Assessment Functionality:

Empowering organizations with greater autonomy, CyberCAST 3.0 introduces self-assessment capabilities, previously available only through consulting services. With fewer than 200 questions, users can conduct assessments independently, receiving a projected score before engaging with Zyston’s cybersecurity experts. This streamlined process enhances customer engagement, reduces overhead, and accelerates the assessment process, delivering unparalleled value to users in under two minutes.

4. Unified Architecture for Seamless Data Integration:

To streamline operations and enhance user experience, CyberCAST 3.0 features a unified architecture that seamlessly integrates data from the Blue Lava platform. Combining the CyberCAST platform with the recently acquired Blue Lava platform has created a clear industry leader in software-driven cybersecurity program management, empowering organizations to make informed decisions and proactively mitigate cyber risks.

5. Enhanced Board-Targeted Reporting:

Recognizing the need for clear and concise communication with executive leadership and board members, CyberCAST 3.0 introduces board-targeted reporting capabilities. Users can now generate high-quality artifacts directly within the platform, including gauges, historical diagrams, and roadmaps, tailored for executive presentations. This feature facilitates informed decision-making and enables organizations to effectively communicate cybersecurity risks and initiatives to key stakeholders, ensuring continuous threat exposure management is prioritized.

6. Peer Score Comparison:

CyberCAST 3.0 introduces peer score comparison functionality, answering the call from customers eager to benchmark their cybersecurity performance against industry peers. Leveraging a proven model established by Blue Lava, this feature empowers organizations to gain valuable insights into their competitive standing within their respective sectors.

By comparing their cybersecurity posture against industry benchmarks, businesses can strategically allocate resources, identify areas for improvement, and bolster their defenses against evolving threats. In today’s ever-evolving digital landscape, CyberCAST 3.0’s peer score comparison provides a critical tool for organizations to proactively enhance their cybersecurity resilience and stay ahead of emerging threats.

Zyston’s CyberCAST 3.0 represents a significant leap forward in cybersecurity program management technology, empowering organizations to proactively identify, mitigate, and manage cybersecurity risks with confidence. To learn more about CyberCAST 3.0 and Zyston’s comprehensive cybersecurity solutions, visit https://www.zyston.com/cybercast-software/.

About Zyston:

Zyston is a leading provider of end-to-end cybersecurity solutions, offering consulting, managed services, and AI-driven software to help businesses build and operate robust information security programs. With a focus on innovation and customer satisfaction, Zyston is dedicated to empowering organizations to safeguard their digital assets and achieve cybersecurity resilience. For more information, visit www.zyston.com.

Share This Post

We're Ready to Listen

CONTACT US
Categories
Company News

SG Homecare Buys Western Drug Medical Supply,
 Fueling Growth in California and Beyond

News and Insights

Index

SG Homecare Buys Western Drug Medical Supply,
 Fueling Growth in California and Beyond

Tustin, CA, May 8, 2024 – SG Homecare, Inc., a leading provider of in-home medical equipment and supplies, announced today the acquisition of Western Drug Medical Supply. This strategic move unites two industry leaders, creating a platform to dramatically scale a leading force in Southern California’s homecare market.

The combined entity boasts:

  • Over $150 million in annual revenue
  • A growing workforce exceeding 500 dedicated employees
  • An expansive product portfolio including durable medical equipment, respiratory solutions, mobility assistance, orthotics and prosthetics, and essential homecare supplies.

Scale Delivers Enhanced Service and Increased Reach

“This is a transformative moment for both SG Homecare and Western Drug Medical Supply,” declares Jay Wendt, CEO of SG Homecare. “We’re committed to a seamless integration, fostering a powerful platform for growth. By leveraging our combined size and resources, we will significantly expand our reach and ability to serve patients and partners across Southern California.”

Shared Vision for Category Leading Patient Care

Haig Youredjian, President and CEO of Western Drug Medical Supply, echoes the sentiment, stating, “We are thrilled to join forces with SG Homecare. Together, we establish an unparalleled network of care, offering a wider range of products and expertise to patients and healthcare professionals throughout California.”

About SG Homecare

For over two decades, SG Homecare has been a trusted provider of durable medical equipment, disposable medical supplies, respiratory therapies, mobility solutions, orthotics and prosthetics, and enteral nutrition solutions across California. Their patient-centric team strives to deliver exceptional service to every individual they serve.

About Western Drug Medical Supply

Western Drug Medical Supply, a Southern California mainstay for over 40 years, has been a leading supplier of high-quality durable medical equipment and supplies. Founded in 1977 by Jack Youredjian, and nurtured by his son Haig Youredjian, the company has built a stellar reputation for exceptional service and product offerings.

Together, SG Homecare and Western Drug Medical Supply embark on a new chapter, dedicated to providing patients and providers with unparalleled in-home care solutions throughout Southern California and beyond.

Share This Post

We're Ready to Listen

CONTACT US
Categories
Company News

ShadowDragon Wins 2024 Frost & Sullivan Best Practices Award for Excellence in Global Open-Source Intelligence

News and Insights

Index

ShadowDragon Wins 2024 Frost & Sullivan Best Practices Award for Excellence in Global Open-Source Intelligence

March 26, 2024 – As a pioneer of open-source intelligence (OSINT) investigation tools dating back to 2009, ShadowDragon is honored by a recent award recognizing us as a transparent and reliable vendor that supports security operations aligned with ethical standards. In other words, an independent evaluation of our company supports our stance that ShadowDragon is the leading voice of “OSINT for Good”.

Frost & Sullivan has presented ShadowDragon with the 2024 Best Practices Award for Entrepreneurial Company of the Year (global OSINT industry). “The company recognizes the level of trust OSINT cyber threat intelligence is built upon; therefore, trust in the OSINT industry is no different when working with clients.”

Award nominees for the Best Practices Awards program are rigorously analyzed, including a detailed evaluation of best practices criteria across two dimensions for each nominated company. According to Frost & Sullivan, ShadowDragon displays an overall strong performance in each category of entrepreneurial innovation and customer impact: market disruption and market gaps, competitive differentiation, leadership focus, passionate persistence, price and performance value, customer purchase and ownership experience, and customer service experience.

Within the official award write-up by Frost & Sullivan, there are a few notes we are especially proud to see that the analyst team took notice of when evaluating ShadowDragon:

  • Our tools address critical challenges in the market, such as manual processing and data collection, lack of targeted data set groups, and the need for source identification. Frost & Sullivan notes that many other competitors in the industry mass collect data and often run artificial intelligence (AI) against a database to produce results, outsourcing where the data came from to conclude their research. ShadowDragon commits to designing its tool without leveraging AI engines so investigators can recreate an investigation independently. 
  • We also develop our solutions with an overall vision to provide “OSINT for good.” We allow investigators to obtain data while adhering to the ethical use of public data. The ShadowDragon platform avoids using AI on behalf of an analyst. Instead, we leverage automation and OSINT to help security teams solve problems and find criminals. We focus on building out our investigative toolkit capabilities to provide the best coverage.
  • Another key differentiator of ShadowDragon is that many competitors do not offer direct application programming interface (API) integration. Most companies offering this feature only integrate with 40 platforms, whereas ShadowDragon can incorporate with 200. For example, we offer a link analysis tool to access data and internal OSINT tools. Instead of developing new or niche-analysis-type platforms, we focus on delivering valuable, comprehensive link analysis. 
  • Last but not least, we venture to great lengths to ensure seamless integration and simplify the buying process for its clients. Unlike other competitors, Frost & Sullivan notes that ShadowDragon builds its solutions, collaborating closely with various stakeholders and partners to evolve alongside market needs and trends. We maintain our role as an educator and adhere to customers of all skill types. For example, customers needing more experience in OSINT platforms can use ShadowDragon’s Internal Monitoring approach. This approach trains security teams while leveraging their knowledge capability when building the platform. Moreover, this training structure helps the company connect with clients familiar with OSINT platforms, determining their skill levels and how to approach each customer best.

In appreciation of this award, our founder, Daniel Clemens, shares:

“ShadowDragon has always been dedicated to making the world a safer place. For our company, this looks like continuously innovating and developing easy-to-use digital investigation tools that simplify the complexities of modern online investigations. Everything from our tools, data and training courses are designed to enable those providing protection to their communities – including public servants, corporate organizations, vetted law enforcement, governments and militaries – to focus on effective investigation and analysis of OSINT and publicly available information (PAI) to solve challenging criminal cases. We thank Frost & Sullivan for including us in their market analysis of OSINT companies, and for highlighting the ways we are leading this space in entrepreneurial innovation.”

“ShadowDragon’s approach exceeds its extensive expertise and best-in-class capabilities, with customer value as a strategic imperative. Through the years, the company has earned a sterling reputation supporting clients’ paths toward efficient investigations.” The ShadowDragon Intelligence Suite not only provides better insights into who the players are and who they may be related to – it fits into multiple different verticals with different use cases at scale, from building cases against organized crime to managing public health crises and physical threats against employees. For more information about the ShadowDragon suite of OSINT tools and capabilities, such as SocialNet, OIMonitor, MalNet and Horizon, visit https://shadowdragon.io/.

The ShadowDragon team will be at several forthcoming events and would look forward to meeting anyone interested in learning more about us – get in touch to find out where. Don’t forget to listen to our latest podcast episodes for research-based thought leadership perspectives on the OSINT space.

About ShadowDragon

ShadowDragon provides comprehensive, cyber investigative resources and training for use by private companies, intelligence gathering professionals, law enforcement, and government. The U.S.-based company delivers open source intelligence (OSINT) from over 200 networks including social media platforms, chat rooms, forums, historical datasets, and the dark web. The company monitors malware history, data breach dumps, and other areas for active cyber threats. These data collection and analytic tools help defend against malicious acts in the digital and physical world. For more information, visit www.shadowdragon.io.

About Frost & Sullivan Global Product Leadership Awards

Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid market acceptance. The award recognizes the quality of the solution and the customer value enhancements it enables.

Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

Share This Post

We're Ready to Listen

CONTACT US
Categories
Company News

fullthrottle.ai’s AI Buyer Propensity Model Wins Business Intelligence Award

News and Insights

Index

fullthrottle.ai’s AI Buyer Propensity Model Wins Business Intelligence Award

March 20, 2024 – fullthrottle.ai offers a unique solution in the AdTech industry by accurately identifying previously unknown website visitors down to their household address. Our AI then assesses buyer propensity, optimizing marketing spend on engaged audiences nearing a transaction.

Balancing the need for powerful, effective AI-driven marketing tools with the imperative to protect user privacy is a delicate task that only a forward-thinking company like fullthrottle.ai can navigate.

It is with great honor that we announce we have won the 2024 Artificial Intelligence Excellence Award for Product Automation from Business Intelligence Group.

This award reinforces our position as a leader in the AdTech space, demonstrating resilience, adaptability, and a commitment to advancing AI technology in a way that positively impacts both the industry and the broader societal context.

You can read the official press release here.

Share This Post

We're Ready to Listen

CONTACT US
Categories
Company News

First Fertility Partners with Fertility Specialists of Texas, expanding its nationwide footprint into Texas

News and Insights

Index

First Fertility Partners with Fertility Specialists of Texas, expanding its nationwide footprint into Texas

Rocky Hill, CT, March 5, 2024 – First Fertility, one of the largest fertility networks in the United States is proud to announce that Fertility Specialists of Texas, a nationally renowned fertility practice with six locations throughout  Dallas-Fort Worth and Lubbock, has joined the First Fertility network. This partnership expands the First Fertility footprint into Texas as part of the company’s vision to exceed the standard of fertility care by providing compassionate, customized fertility services with the highest quality of reproductive technology and treatments.

With locations in North Plano, Dallas, Rockwall, Southlake, and Lubbock, as well as six double-board certified fertility specialist physicians with 100 years of combined experience, The Fertility Specialists of Texas brings a wealth of experience to the First Fertility family of centers.  “The Fertility Specialists of Texas’s reputation for delivering exceptional success rates along with individualized patient-first care aligns perfectly with First Fertility’s mission to make compassionate, cutting-edge fertility care accessible to anyone who wants to have a baby, “said Cara Reymann, CEO of First Fertility, “In addition to our shared commitment of providing patient-focused care, we look forward to bringing our shared service infrastructure to The Fertility Specialists of Texas, providing ongoing investments in the latest technologies in reproductive medicine and freeing up clinical teams to focus on what always comes first: the patient”

“As the founder and medical director of Fertility Specialists of Texas, I am immensely excited to embark on this incredible journey alongside First Fertility,” adds Jerald Goldstein, MD. “This partnership represents a remarkable opportunity to unite our expertise and passion for reproductive medicine, driving us to reach new heights in assisting individuals and couples on their path to parenthood. Together, we will shape the future of fertility with compassion and unparalleled personalized care, as we continue to help patients from Texas, throughout the country, and around the world, to fulfill their family-building dreams.”

About Fertility Specialists of Texas

For more than 18 years, FST has helped thousands of patients overcome infertility and carries a reputation for success with both quality of care and pregnancy and live birth rates. Led by a top-notch IVF laboratory, FST strives to provide the most advanced fertility treatments available in a caring, compassionate environment where each patient is treated as an individual beginning with the first visit. To learn more, visit fertilitytexas.com.

About First Fertility

First Fertility offers comprehensive and customized care for patients hoping to grow their families. We not only invest in reproductive endocrinology practices nationwide, but we also build strategic partnerships that put the focus on what matters most: taking care of patients. First Fertility has 37 locations in North America, serving patients in 13 states, including Alabama, Connecticut, Florida, Illinois, Louisiana, Maine, Massachusetts, Mississippi, Missouri, New Hampshire, New York, Oklahoma, Rhode Island, and Texas. Learn more at firstfertility.com.

Share This Post

We're Ready to Listen

CONTACT US
Categories
Company News

Fertility Centers of New England Acquires Fertility Solutions to Expand First Fertility Network

News and Insights

Index

Fertility Centers of New England Acquires Fertility Solutions to Expand First Fertility Network

Rocky Hill, CT, February 6, 2024 – First Fertility, one of the largest fertility networks in the United States announced today that Fertility Centers of New England, a First Fertility Center of Excellence, has acquired Fertility Solutions, a fertility center based in Massachusetts with offices also in Rhode Island. This partnership adds six new locations and four highly regarded, experienced, and compassionate physicians to Fertility Centers of New England, furthering the company’s vision to make fertility treatment more accessible in every community that we serve.

“This strategic acquisition expands Fertility Centers of New England’s ability to provide high-quality reproductive care from Falmouth, ME to Providence, RI through its now 18 locations, two IVF laboratories, and 9 physicians, “said Cara Reymann, CEO of First Fertility, “In addition to expanding our footprint in the region, we look forward to continuing to provide the highest quality of care to patients and an expanded tier of support to the staff.”

“The dedication to patient care of the physicians and staff at Fertility Solutions is well known in the region and we are delighted to have them join FCNE,” said Joseph A. Hill, M.D., President of FCNE. “Our shared philosophy of putting patients first is a natural fit. With equal measure of compassion and skill, we have helped thousands build healthy families. Now even more people throughout New England and beyond will be able to realize their dream of parenthood,” said Dr. Hill.

“My colleagues and I are excited to join FCNE, “said Dr. Ania Kowalik, Partner at Fertility Solutions. “We look forward to continuing our tradition of providing outstanding care to those needing our services as part of Fertility Centers of New England,” she continued.

About Fertility Centers of New England
Fertility Centers of New England is an international leader in the evaluation, diagnosis, and treatment of infertility. We combine advanced reproductive technologies with a comforting, supportive environment. Fertility Centers of New England has many convenient locations for treatment and cycle monitoring throughout New England. We accept all insurance plans and offer a range of options for self-pay patients, including donor oocyte cycles.

About First Fertility
First Fertility offers comprehensive and customized care for patients hoping to grow their families. We not only invest in reproductive endocrinology practices nationwide, but we also build strategic partnerships that put the focus on what matters most: taking care of patients. First Fertility has 37 locations in North America, serving patients in 13 states, including Alabama, Connecticut, Florida, Illinois, Louisiana, Maine, Massachusetts, Mississippi, Missouri, New Hampshire, New York, Oklahoma, and Rhode Island. Learn more at firstfertility.com.

Share This Post

We're Ready to Listen

CONTACT US
Categories
Company News

Clarest Health Acquires Remedi Senior Care in Strategic Move to Redefine Personalized Medication Management for Aging Population

Doctor attending senior patient using digital tablet

News and Insights

Index

Clarest Health Acquires Remedi Senior Care in Strategic Move to Redefine Personalized Medication Management for Aging Population

Vienna, Va., January 8, 2024 – Clarest Health, a leading personalized medication management provider, announced today that it has acquired Remedi SeniorCare, a long-term and post-acute care pharmacy services provider, giving the company the size and scale to lead the post-acute care market.  The U.S. market for pharmacy care for the post-acute patient population is $5.7 billion, and the U.S. Rx fill market for medically complex patients is $115 billion.1 Financial terms of the acquisition were not disclosed.

“This is an exciting moment for us,” says Hammad Shah, CEO of Clarest Health. “By adding Remedi to our organization, we are uniquely positioned to transform post-acute pharmacy care for aging patients in the hospital, at home, in assisted living communities, and in skilled nursing facilities. Currently, there are many gaps in providing the best medication care to the aging population. We are committed to filling these gaps through technology-based medication optimization and fulfillment.”

This acquisition represents another stake in Clarest Health’s strategy to provide flexible medication management and reduce the complexities that patients and their caregivers face, as patients transition to and from the hospital, skilled nursing facility and home environments. In September 2022, Clarest Health purchased CSS Health whose proprietary technology offers real-time insights to identify vulnerable patients to ensure medication adherence. In October 2022, it purchased Integrity Pharmacy, a “pharmacy at home” service to serve patients in their home environment.  Now, with the acquisition of Remedi, Clarest Health expands its geographic footprint and technological capabilities.

“Remedi and Clarest share a mutual vision of embracing technology to provide patient-focused, pharmacy services and solutions,” said Jeff Stamps, CEO of Remedi SeniorCare. “We will combine Remedi’s proprietary, patented automation technology, PAXIT®, and customer portal, MyRemedi®, with Clarest Health’s post-acute medication management capabilities and data analytics to improve health outcomes.”

Today, multiple critical factors require a comprehensive approach to personalized medication management for patients including an aging population in which all baby boomers will be 65 years and older by the year 2030 ( U.S. Census).  Research shows that family members need better support to care for their aging parents. At least 17.7 million individuals in the U.S. are caregivers of an older adult, and 61 percent of family caregivers are women resulting in high stress.2.,3.

Additionally, the estimated annual cost of drug-related morbidity and mortality resulting from nonoptimized medication therapy was $528.4 billion equivalent to 16 percent of total U.S. healthcare expenditures in 2016 (NIH report).

 

About Remedi SeniorCare

Headquartered in Towson, Maryland, technology-enabled pharmacy services company Remedi SeniorCare partners with long-term and institutional care facilities to provide exceptional person-centered medication management programs and achieve improved business results through innovation, advanced technology solutions, and clinical expertise. Renowned for its long-term care pharmacy services and proprietary medication management system PAXIT® and its customer portal, MyRemedi®, Remedi SeniorCare leads medication adherence in Skilled Nursing facilities and Assisted Living communities.

About Clarest Health

As a mission-driven pharmacy health expert, Clarest Health offers an end-to-end, patient-centered medication management solution to support patients in optimizing, accessing, and adhering to, their medication regimen. Our flexible, comprehensive services integrate technology, human engagement, and proven processes to Advance Patient’s Health at Every Step while enabling our partners to achieve better business outcomes. For more information, visit www.clarest.com.

 

1. Source: L.E.K interviews research and analysis
2. Family Caregivers’ Interactions with Health Care and Long-Term Services and Supports – Families Caring for an Aging America – NCBI Bookshelf (nih.gov)
3. Caregiving in the U.S. 2020: A Focused Look at Family Caregivers of Adults Age 50+ – AARP Research Report Companion

Share This Post

We're Ready to Listen

CONTACT US
Categories
Sverica News

Sverica Capital Management Announces the Promotions of Greg Hylant to Principal and Franklin Shieh to Vice President

News and Insights

Index

Sverica Capital Management Announces the Promotions of Greg Hylant to Principal and Franklin Shieh to Vice President

Boston, Austin and San Francisco – January 2, 2024 – Sverica Capital Management, a leading growth-oriented private equity firm focused on the lower middle market, announced today the promotions of Greg Hylant to Principal and Franklin Shieh to Vice President.

Greg has been an important member of Sverica’s Boston office since joining the firm in 2014. He focuses on sourcing and evaluating new investment opportunities, industry research, and portfolio company operations for Advanced Industrial companies. He graduated from Duke University and received a Master’s in Management Studies from Fuqua School of Business. Greg currently serves as a Board Member of Gener8, Hirebotics, and InflexionPoint.

Franklin joined Sverica’s San Francisco office in 2022 and focuses on sourcing investment opportunities and supporting portfolio companies for Sverica’s technology practice. Franklin earned his B.S. in Business Administration from USC and his MBA from Columbia Business School.

Share This Post

We're Ready to Listen

CONTACT US
Categories
Company News

First Stop Health Announces Acquisition of SentryHealth

Telehealth: First Stop Health Acquires SentryHealth

News and Insights

Index

First Stop Health Announces Acquisition of SentryHealth

Chicago, IL – November 2, 2023 – First Stop Health, a leading virtual care company for primary, urgent and mental health care needs, announced today the acquisition of SentryHealth Inc., an employee health and well-being platform. 

SentryHealth is an AI-driven care management and advocacy solution that focuses on personalized care. Its programs will enhance FSH’s virtual care solutions and strengthen its offerings for employers and their employees. The two companies are aligned in providing high-quality, low-to-no-cost, patient-centered care. 

“SentryHealth enriches our virtual care offerings with care advocacy and improved navigation to help patients feel supported and engaged in their health,” says Teira Gunlock, CEO of First Stop Health. “By continuing to expand on providing delightful healthcare experiences to our members, we are poised to deliver more value to our employer-clients. 2023 has been a year of thrilling growth in the number of patients we serve and in how we can help them live healthier lives.”  

“This represents a strategic alignment of vision and values,” says Kevin Porter, President & CEO of SentryHealth. “Through a shared focus on quality, accessibility and cost savings, together we are poised to create a healthcare experience that supports better employee health and wellbeing and contributes to the overall success of our clients.”

Teira Gunlock will be CEO of the combined company with Kevin Porter joining as a Strategic Advisor. The recent strategic investment of Sverica Capital Management and recognition in Inc. Magazine’s 5000 Fastest Growing Companies list represents a time of significant growth for FSH. The acquisition of SentryHealth will bolster this growth with added talent and services. 

As a virtual medical home designed for everyone, FSH and SentryHealth’s care tactics will deliver unparalleled experiences to its members. FSH’s Virtual Primary Care was launched in 2022 based on the response to patient need for accessible, value-based care and to specifically address preventive, chronic disease and mental health care. FSH Virtual Primary Care is the one-stop for whole-person health guidance. There is no one-size-fits-all solution for patients, and the acquisition of SentryHealth will further support both companies’ dedication to delivering personalized care that people love.®   

About SentryHealth Inc.

SentryHealth is leading the charge in employee health and well-being. Its integrated health solution is the perfect combination of technology and personalized support from caring medical professionals. The company analyzes data from multiple sources to develop unique Intelligent Profiles complete with personalized recommendations. Pairing these profiles with smart technology and Registered Nurse Advocates, it engages with each employee to ensure they receive the right care at the right time. The result is better participation, higher satisfaction, greater outcomes, and lower costs. 

About First Stop Health 

First Stop Health (FSH) provides care that people love® with various digital healthcare services. Patients can access virtual care 24/7 via app, website or phone. We help them save time and money with safe, convenient, high-quality virtual care solutions – Primary Care, Urgent Care & Mental Health. FSH was named one of Inc. Magazine’s Best Workplaces of 2022 and 2023, and ranked one of the fastest-growing private companies for the past 5 years by Inc. 5000. In 2023, FSH was also recognized in Crain’s Chicago Business Fast 50 as one of the Chicago-areas’ fastest growing companies and as a 2023 Well-Being Trailblazer presented by Archetype and WELCOA. For more information, please visit www.fshealth.com. 

 

Share This Post

We're Ready to Listen

CONTACT US
Categories
Sverica News

Sverica Capital Management Named to Inc.’s 2023 List of Founder-Friendly Investors

Inc.'s Founder Friendly Honoree 2023

News and Insights

Index

Sverica Capital Management Named to Inc.’s 2023 List of Founder-Friendly Investors

Boston, MA, Austin, TX and San Francisco, CA – November 2, 2023 – Sverica Capital Management LP (“Sverica”), a private equity investment firm, announced today that it has been named as a Founder-Friendly Investor by Inc.  

To compile the list, Inc. went to the source: entrepreneurs who have sold to private equity and venture capital firms. Founders filled out a questionnaire about their experiences partnering with private equity, venture capital, and debt firms and shared data on how their portfolio companies have grown during these partnerships.

“Inclusion in this list is particularly meaningful for Sverica as partnering with talented founders and entrepreneurs is at the core of what we do.  We are honored to go on each and every growth journey with our business leaders as they strive to build companies that will outpace their competition while staying true to their core values and providing great opportunities for their team members.  We would like to thank all of the Founders that have trusted us as their partners over the 22 years Sverica has been in business.” said Dave Finley, Jordan Richards, and Frank Young, Sverica’s Managing Partners.

Disclosure Note:  Selections for the award are based on Inc’s survey of Sverica portfolio company founders. To view the full list of honorees and read more about the selection methodology, visit Inc’s website. The awards and designations are the opinions of the respective parties conferring the award or designation and not of Sverica Capital Management. Sverica submitted a nomination to be considered for the Inc award, and paid a fee to participate and distribute the results. There can be no assurance that other providers or surveys would reach the same conclusion as the foregoing. Recognitions by third-parties are not indicative of future performance.

Share This Post

We're Ready to Listen

CONTACT US